During the Presidential Plenary, investigator Dr. Eric Lim shared data comparing surgery plus chemotherapy to chemotherapy alone, one of several potentially practice-changing studies presented during the session. Read more

Data presented by patient advocate Jill Feldman and Nathan Harrison show that while the IASLC’s Language Guide is helping to reduce the use of stigmatizing language, research on the effects of stigma in lung cancer is lacking. Read more

In addition to thought-provoking keynotes from Her Royal Highness Princess Dina Mired and Dr. Gary Rodin, the official kickoff of #WCLC23 included a lively celebration of the meeting’s host city. Read more

Investigator Dr. Ying Cheng says study results support the use of immunochemotherapy plus anti-angiogenesis as a new treatment option in a difficult-to-treat patient population. Read more

In an exclusive interview, Princess Dina talks with ILCN about her passion for improving equitable access to cancer care, tobacco control, prevention, and more. Read more

IASLC President Dr. Heather Wakelee discusses what WCLC—this year and every year—offers the thoracic oncology community. Read more

Participants have spent months crafting case summaries, and WCLC attendees will have an opportunity to vote for their favorites. Read more

Stay active during your time in Singapore by taking part in IASLC’s annual wellness challenge, Step It Up For Research. Read more

While in Singapore, plan to join your colleagues at the historic Clifford Pier for an evening of food, drink, and entertainment while raising funds for lung cancer research. Read more

From opportunities specifically for first-time attendees or allied health professionals to sessions focused on communication skills or Latin America, the first day of WCLC 2023 has something for everyone. Read more